GlassScriptPhysician profile
Dana C Collins
NPI 1447312442
$14,446.18
in general payments reported to CMS, 2019-2025
56 companies · $2,124 in 2025
The $2,124 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $640 · 2020: $1,347 · 2021: $2,311 · 2022: $2,550 · 2023: $3,089 · 2024: $2,385 · 2025: $2,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,573 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,572.64 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,349.56 | 2019-2025 | Rinvoq, Skyrizi, Ubrelvy |
| Amgen INC. | $1,854.56 | 2019-2025 | Otezla, Enbrel, Enbrel |
| Ucb, INC. | $1,629.06 | 2019-2025 | Cimzia, Bimzelx |
| Novartis Pharmaceuticals Corporation | $1,258.33 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $936.74 | 2020-2025 | Acthar |
| Glaxosmithkline, LLC. | $837.78 | 2019-2025 | Benlysta, Nucala, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $691.41 | 2019-2025 | Ofev, Jardiance, Tradjenta |
| Janssen Biotech, INC. | $601.60 | 2020-2025 | Tremfya |
| Lilly USA, LLC | $428.08 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Mannkind Corporation | $364.48 | 2020-2022 | |
| Novo Nordisk INC | $241.92 | 2019-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $240.09 | 2021-2024 | |
| Organon LLC | $219.16 | 2023-2024 | Hadlima, Renflexis |
| Sumitomo Pharma America, INC. | $188.99 | 2023-2024 | Gemtesa |
| Daiichi Sankyo INC. | $188.81 | 2020-2022 |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.